Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology
Lists
Only you see this
Abstract
The Precision Neurology development process implements systems theory with system biology and neurophysiology in a parallel, bidirectional research path: a combined hypothesis-driven investigation of systems dysfunction within distinct molecular, cellular, and large-scale neural network systems in both animal models as well as through tests for the usefulness of these candidate dynamic systems biomarkers in different diseases and subgroups at different stages of pathophysiological progression. This translational research path is paralleled by an "omics"-based, hypothesis-free, exploratory research pathway, which will collect multimodal data from progressing asymptomatic, preclinical, and clinical neurodegenerative disease (ND) populations, within the wide continuous biological and clinical spectrum of ND, applying high-throughput and high-content technologies combined with powerful computational and statistical modeling tools, aimed at identifying novel dysfunctional systems and predictive marker signatures associated with ND. The goals are to identify common biological denominators or differentiating classifiers across the continuum of ND during detectable stages of pathophysiological progression, characterize systems-based intermediate endophenotypes, validate multi-modal novel diagnostic systems biomarkers, and advance clinical intervention trial designs by utilizing systems-based intermediate endophenotypes and candidate surrogate markers. Achieving these goals is key to the ultimate development of early and effective individualized treatment of ND, such as Alzheimer's disease. The Alzheimer Precision Medicine Initiative (APMI) and cohort program (APMI-CP), as well as the Paris based core of the Sorbonne University Clinical Research Group "Alzheimer Precision Medicine" (GRC-APM) were recently launched to facilitate the passageway from conventional clinical diagnostic and drug development toward breakthrough innovation based on the investigation of the comprehensive biological nature of aging individuals. The APMI movement is gaining momentum to systematically apply both systems neurophysiology and systems biology in exploratory translational neuroscience research on ND.
BibTeX
@article{hampel2018revolution,
author = {Harald Hampel and Nicola Toschi and Claudio Babiloni and Filippo Baldacci and Keith L. Black and Arun L.W. Bokde and René Sosata Bun and Francesco Cacciola and Enrica Cavedo and Patrizia A. Chiesa and Olivier Colliot and Cristina-Maria Coman and Bruno Dubois and Andrea Duggento and Stanley Durrleman and Maria-Teresa Ferretti and Nathalie George and Remy Genthon and Marie‐Odile Habert and Karl Herholz and Yosef Koronyo and Maya Koronyo‐Hamaoui and Foudil Lamari and Todd Langevin and Stéphane Lehéricy and Jean Lorenceau and Christian Néri and Robert Nisticò and Francis Nyasse-Messene and Craig Ritchie and Símone Rossi and Emiliano Santarnecchi and Olaf Sporns and Steven Verdooner and Andrea Vergallo and Nicolas Villain and Erfan Younesi and Francesco Garaci and Simone Lista and Simone Lista},
title = {{Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology}},
journal = {Journal of Alzheimer s Disease},
year = {2018},
doi = {10.3233/jad-179932},
}Loading related content...